BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10446115)

  • 1. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.
    Lenzi M; Bellentani S; Saccoccio G; Muratori P; Masutti F; Muratori L; Cassani F; Bianchi FB; Tiribelli C
    Gut; 1999 Sep; 45(3):435-41. PubMed ID: 10446115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
    Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
    Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy.
    Squadrito G; Previti M; Lenzi M; Le Rose EP; Caccamo G; Restuccia T; Di Cesare E; Pollicino T; Raimondo G
    Dig Dis Sci; 2003 Feb; 48(2):349-53. PubMed ID: 12643614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population.
    Muratori P; Muratori L; Stroffolini T; Pappas G; Terlizzi P; Ferrari R; Loffreda S; Cassani F; Rapicetta M; Guadagnino V; Bianchi FB; Lenzi M
    Clin Exp Immunol; 2003 Jan; 131(1):118-21. PubMed ID: 12519394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
    Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
    J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.
    Muratori P; Muratori L; Verucchi G; Attard L; Bianchi FB; Lenzi M
    Clin Infect Dis; 2003 Nov; 37(10):1320-6. PubMed ID: 14583865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
    Kirdar S; Sener AG; Cengİz M; Aydin N
    APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of non-organ-specific antibodies in children with genotype 4 chronic hepatitis C.
    Hamed ME; Kamal Alanani NM; Sherief LM; Fouad MA; Elwahab LA; Raafat N
    Saudi J Gastroenterol; 2013; 19(6):262-70. PubMed ID: 24195980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-organ specific autoantibodies in children with chronic hepatitis C.
    Bortolotti F; Vajro P; Balli F; Giacchino R; Crivellaro C; Barbera C; Cataleta M; Muratori L; Pontisso P; Nebbia G; Zancan L; Bertolini A; Alberti A; Bianchi F
    J Hepatol; 1996 Nov; 25(5):614-20. PubMed ID: 8938535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody profile in individuals with chronic hepatitis C.
    Marconcini ML; Fayad L; Shiozawa MB; Dantas-Correa EB; Lucca Schiavon Ld; Narciso-Schiavon JL
    Rev Soc Bras Med Trop; 2013; 46(2):147-53. PubMed ID: 23740063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population.
    Fabrizi F; De Vecchi AF; Qureshi AR; Aucella F; Lunghi G; Bruchfeld A; Bisegna S; Mangano S; Limido A; Vigilante D; Forcella M; Delli Carri P; Martin P
    Int J Artif Organs; 2007 Jan; 30(1):6-15. PubMed ID: 17295188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anti-HLA antibodies in patients with chronic hepatitis C: relation to disease activity.
    El Aggan HA; Sidkey F; El Gezery DA; Ghoneim E
    Egypt J Immunol; 2004; 11(2):71-9. PubMed ID: 16734119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to thyroid disorders in hepatitis C.
    Muratori L; Bogdanos DP; Muratori P; Lenzi M; Granito A; Ma Y; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Gastroenterol Hepatol; 2005 Jun; 3(6):595-603. PubMed ID: 15952102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Carvalhana SC; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):640-4. PubMed ID: 26866523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.